3D Printing of Pharmaceuticals and Transdermal Drug Delivery––An Overview

David Bird, Emel Eker, N. Ravindra

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Three-dimensional printing is a novel technique offering the ability to print transdermal drug delivery systems on demand. Such printing techniques have already been used in the fields of dentistry, orthopedics and pharmaceuticals; highlighting the latter, printing medical devices and various active pharmaceutical ingredient formulations, which possess various geometries with controlled release characteristics, have also been utilized. An overview of these pharmaceuticals is presented in this study, with an emphasis on transdermal patches that can be 3D printed. Several printing technologies and material systems are discussed, which are customizable and generate complex geometries with inherent precision that satisfy the transdermal system and enhance bioavailability. Case studies, advantages and limitations of the technology are discussed. Industry forecasts based on this technology is predicted to reach over USD 8 Billion by 2025, but the pharmaceutical industry is conservative and utilizes cost-effective methods for large-scale production. 3D Printing could revolutionize current ‘one size fits all’ manufacturing and would be utilized throughout the drug development timeline.

Original languageEnglish (US)
Title of host publicationTMS 2019 148th Annual Meeting and Exhibition Supplemental Proceedings
PublisherSpringer International Publishing
Pages1563-1573
Number of pages11
ISBN (Print)9783030058609
DOIs
StatePublished - Jan 1 2019
Event148th Annual Meeting and Exhibition of The Minerals, Metals and Materials Society, TMS 2019 - San Antonio, United States
Duration: Mar 10 2019Mar 14 2019

Publication series

NameMinerals, Metals and Materials Series

Conference

Conference148th Annual Meeting and Exhibition of The Minerals, Metals and Materials Society, TMS 2019
CountryUnited States
CitySan Antonio
Period3/10/193/14/19

Fingerprint

Printing
Technology
Pharmaceutical Preparations
Transdermal Patch
Drug Compounding
Drug Industry
Drug Delivery Systems
Dentistry
Biological Availability
Orthopedics
Industry
Costs and Cost Analysis
Equipment and Supplies
Three Dimensional Printing

All Science Journal Classification (ASJC) codes

  • Electronic, Optical and Magnetic Materials
  • Mechanics of Materials
  • Metals and Alloys
  • Energy Engineering and Power Technology
  • Materials Chemistry

Keywords

  • Pharmaceuticals
  • Three-dimensional printing
  • Transdermal drug delivery systems

Cite this

Bird, D., Eker, E., & Ravindra, N. (2019). 3D Printing of Pharmaceuticals and Transdermal Drug Delivery––An Overview. In TMS 2019 148th Annual Meeting and Exhibition Supplemental Proceedings (pp. 1563-1573). (Minerals, Metals and Materials Series). Springer International Publishing. https://doi.org/10.1007/978-3-030-05861-6_147
Bird, David ; Eker, Emel ; Ravindra, N. / 3D Printing of Pharmaceuticals and Transdermal Drug Delivery––An Overview. TMS 2019 148th Annual Meeting and Exhibition Supplemental Proceedings. Springer International Publishing, 2019. pp. 1563-1573 (Minerals, Metals and Materials Series).
@inproceedings{f09355c69b7f4e8c8b5b2f7ffa8b1da2,
title = "3D Printing of Pharmaceuticals and Transdermal Drug Delivery––An Overview",
abstract = "Three-dimensional printing is a novel technique offering the ability to print transdermal drug delivery systems on demand. Such printing techniques have already been used in the fields of dentistry, orthopedics and pharmaceuticals; highlighting the latter, printing medical devices and various active pharmaceutical ingredient formulations, which possess various geometries with controlled release characteristics, have also been utilized. An overview of these pharmaceuticals is presented in this study, with an emphasis on transdermal patches that can be 3D printed. Several printing technologies and material systems are discussed, which are customizable and generate complex geometries with inherent precision that satisfy the transdermal system and enhance bioavailability. Case studies, advantages and limitations of the technology are discussed. Industry forecasts based on this technology is predicted to reach over USD 8 Billion by 2025, but the pharmaceutical industry is conservative and utilizes cost-effective methods for large-scale production. 3D Printing could revolutionize current ‘one size fits all’ manufacturing and would be utilized throughout the drug development timeline.",
keywords = "Pharmaceuticals, Three-dimensional printing, Transdermal drug delivery systems",
author = "David Bird and Emel Eker and N. Ravindra",
year = "2019",
month = "1",
day = "1",
doi = "https://doi.org/10.1007/978-3-030-05861-6_147",
language = "English (US)",
isbn = "9783030058609",
series = "Minerals, Metals and Materials Series",
publisher = "Springer International Publishing",
pages = "1563--1573",
booktitle = "TMS 2019 148th Annual Meeting and Exhibition Supplemental Proceedings",

}

Bird, D, Eker, E & Ravindra, N 2019, 3D Printing of Pharmaceuticals and Transdermal Drug Delivery––An Overview. in TMS 2019 148th Annual Meeting and Exhibition Supplemental Proceedings. Minerals, Metals and Materials Series, Springer International Publishing, pp. 1563-1573, 148th Annual Meeting and Exhibition of The Minerals, Metals and Materials Society, TMS 2019, San Antonio, United States, 3/10/19. https://doi.org/10.1007/978-3-030-05861-6_147

3D Printing of Pharmaceuticals and Transdermal Drug Delivery––An Overview. / Bird, David; Eker, Emel; Ravindra, N.

TMS 2019 148th Annual Meeting and Exhibition Supplemental Proceedings. Springer International Publishing, 2019. p. 1563-1573 (Minerals, Metals and Materials Series).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

TY - GEN

T1 - 3D Printing of Pharmaceuticals and Transdermal Drug Delivery––An Overview

AU - Bird, David

AU - Eker, Emel

AU - Ravindra, N.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Three-dimensional printing is a novel technique offering the ability to print transdermal drug delivery systems on demand. Such printing techniques have already been used in the fields of dentistry, orthopedics and pharmaceuticals; highlighting the latter, printing medical devices and various active pharmaceutical ingredient formulations, which possess various geometries with controlled release characteristics, have also been utilized. An overview of these pharmaceuticals is presented in this study, with an emphasis on transdermal patches that can be 3D printed. Several printing technologies and material systems are discussed, which are customizable and generate complex geometries with inherent precision that satisfy the transdermal system and enhance bioavailability. Case studies, advantages and limitations of the technology are discussed. Industry forecasts based on this technology is predicted to reach over USD 8 Billion by 2025, but the pharmaceutical industry is conservative and utilizes cost-effective methods for large-scale production. 3D Printing could revolutionize current ‘one size fits all’ manufacturing and would be utilized throughout the drug development timeline.

AB - Three-dimensional printing is a novel technique offering the ability to print transdermal drug delivery systems on demand. Such printing techniques have already been used in the fields of dentistry, orthopedics and pharmaceuticals; highlighting the latter, printing medical devices and various active pharmaceutical ingredient formulations, which possess various geometries with controlled release characteristics, have also been utilized. An overview of these pharmaceuticals is presented in this study, with an emphasis on transdermal patches that can be 3D printed. Several printing technologies and material systems are discussed, which are customizable and generate complex geometries with inherent precision that satisfy the transdermal system and enhance bioavailability. Case studies, advantages and limitations of the technology are discussed. Industry forecasts based on this technology is predicted to reach over USD 8 Billion by 2025, but the pharmaceutical industry is conservative and utilizes cost-effective methods for large-scale production. 3D Printing could revolutionize current ‘one size fits all’ manufacturing and would be utilized throughout the drug development timeline.

KW - Pharmaceuticals

KW - Three-dimensional printing

KW - Transdermal drug delivery systems

UR - http://www.scopus.com/inward/record.url?scp=85064878716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064878716&partnerID=8YFLogxK

U2 - https://doi.org/10.1007/978-3-030-05861-6_147

DO - https://doi.org/10.1007/978-3-030-05861-6_147

M3 - Conference contribution

SN - 9783030058609

T3 - Minerals, Metals and Materials Series

SP - 1563

EP - 1573

BT - TMS 2019 148th Annual Meeting and Exhibition Supplemental Proceedings

PB - Springer International Publishing

ER -

Bird D, Eker E, Ravindra N. 3D Printing of Pharmaceuticals and Transdermal Drug Delivery––An Overview. In TMS 2019 148th Annual Meeting and Exhibition Supplemental Proceedings. Springer International Publishing. 2019. p. 1563-1573. (Minerals, Metals and Materials Series). https://doi.org/10.1007/978-3-030-05861-6_147